How melanoma cells inactivate NK cells

OncoImmunology

Volumn 1, Issue 6, 2012, Pages 974-975

  Pietra, Gabriella ^a   Vitale, Massimo ^b   Moretta, Lorenzo ^c   Mingari, Maria Cristina ^a,b,d  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d Centro di Eccellenza per la Ricerca Biomedica   (Italy)

Author keywords

IDO; Melanoma cells; NK cells; PGE2; Tumor escape

Indexed keywords

GAMMA INTERFERON; GRANZYME A; HLA ANTIGEN CLASS 1; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINASE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; PROSTAGLANDIN E2;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CELL INTERACTION; ENZYME INHIBITION; HUMAN; IMMUNOMODULATION; MELANOMA CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; T LYMPHOCYTE; TUMOR MICROENVIRONMENT;

EID: 84886944816     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.20405     Document Type: Article

References (10)

1. Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol 2011; 29:235-71; PMID:21219185; http://dx.doi.org/10.1146/annurev-immunol-031210-101324.
2. Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 2000; 356:1795-9; PMID:11117911; http://dx.doi.org/10.1016/S0140-6736(00)03231-1.
3. Sutlu T, Alici E. Natural killer cell-based immuno-therapy in cancer: current insights and future prospects. J Intern Med 2009; 266:154-81; PMID:19614820; http://dx.doi.org/10.1111/j.1365-2796.2009.02121.x.
4. Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest 2011; 121:3609-22; http://dx.doi.org/10.1172/JCI45816; PMID:21841316.
5. Platonova S, Cherfils-Vicini J, Damotte D, Crozet L, Vieillard V, Validire P, et al. Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Cancer Res 2011; 71:5412-22; PMID:21708957; http://dx.doi.org/10.1158/0008-5472.CAN-10-4179.
6. Balsamo M, Vermi W, Parodi M, Pietra G, Manzini C, Queirolo P, et al. Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor. Eur J Immunol 2012; In press; http://dx.doi.org/10.1002/eji.201142179.
7. Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, et al. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res 2012; 72:1407-15; PMID:22258454; http://dx.doi.org/10.1158/0008-5472.CAN-11-2544.
8. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity and cytokine production: role of indoleamine-2,3-dioxy-genase and prostaglandin E2. Blood 2008; 111:1327-33; PMID:17951526; http://dx.doi.org/10.1182/blood-2007-02-074997.
9. Balsamo M, Scordamaglia F, Pietra G, Manzini C, Cantoni C, Boitano M, et al. Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. Proc Natl Acad Sci USA 2009; PMID: 19934056.
10. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Münz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002; 195:343-51; PMID:11828009; http://dx.doi. org/10.1084/jem.20011149.